Cargando…
Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients
IMPORTANCE: Biosimilars, or highly similar versions of complex biologic drugs, have the potential to slow drug spending growth; however, biosimilar uptake in the United States has been slow. Little is known about barriers to biosimilar uptake following drug launch. OBJECTIVE: To examine the patient,...
Autores principales: | Dean, Emma Boswell, Johnson, Phyllis, Bond, Amelia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841457/ https://www.ncbi.nlm.nih.gov/pubmed/33502485 http://dx.doi.org/10.1001/jamanetworkopen.2020.34776 |
Ejemplares similares
-
Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market
por: Dean, Emma Boswell, et al.
Publicado: (2021) -
Time and Financial Costs for Physician Practices to Participate in the Medicare Merit-based Incentive Payment System: A Qualitative Study
por: Khullar, Dhruv, et al.
Publicado: (2021) -
Association of Health Insurance Literacy With Enrollment in Traditional Medicare, Medicare Advantage, and Plan Characteristics Within Medicare Advantage
por: Park, Sungchul, et al.
Publicado: (2022) -
Association of Variation in Consultant Use Among Hospitalist Physicians With Outcomes Among Medicare Beneficiaries
por: Stevens, Jennifer P., et al.
Publicado: (2020) -
Physician Practice Leaders’ Perceptions of Medicare’s Merit-Based Incentive Payment System (MIPS)
por: Khullar, Dhruv, et al.
Publicado: (2021)